Dr. Nolan Williams: Psychedelics & Neurostimulation for Brain Rewiring

In this episode of the Huberman Lab Podcast, Andrew Huberman interviews Dr. Nolan Williams about depression and mood disorders. They discuss the neurocircuitry of depression, including the connection between the dorsolateral prefrontal cortex and heart rate, and explore various treatments such as TMS, SSRIs, ketamine, psilocybin, MDMA, ibogaine, ayahuasca, cannabis, sleep deprivation, and light exposure. They emphasize the importance of understanding the underlying biology and neural networks involved in depression, as well as the potential for combining different treatments to achieve more effective and durable relief. The conversation also touches on the role of beliefs, cognitive control, and the potential for psychedelics to facilitate new perspectives and emotional regulation.

Outlines

Sign in to continue reading, translating and more.

Continue

Huberman Lab

Introduction to Depression and Psychedelic Treatments

The Debilitating Nature of Depression and its Impact on Physical Health

The Disparity in Acute Care for Psychiatric vs. Physical Illnesses and Brain-Heart Connections

Lateralization of Function in the Dorsolateral Prefrontal Cortex

Heart Rate Variability, Depression, and Behavioral Interventions

The Role of the Parasympathetic Nervous System and the Dorsolateral Prefrontal Cortex in Mood Regulation

The Stroop Task, Belief Systems, and the Dorsolateral Prefrontal Cortex

The Role of TMS in Enhancing Cognitive Function and the Timing of Brain Regions in Depression

The Cingulate Cortex, Dissociation, and Contrasting Drug Effects on Depression

Ketamine's Mechanism of Action and the Importance of Underlying Biology in Psychedelic Treatments

SSRIs, Serotonin, and the Circuitry of Depression

The Power of Control and the Role of Psychedelics in Recovering from Psychiatric Illnesses

MDMA and its Effects on Trauma and the Brain

Serotonin, Dopamine, and the Effects of Psilocybin on the Brain

Exposure Response Prevention Therapy and the Spectrum of Mental Health

Ibogaine: A Unique Psychedelic for Addiction and Trauma

5-MeO-DMT, Ayahuasca, and the Potential for Psychedelics in Criminal Rehabilitation

Cannabis: CBD vs. THC and the Risks for Developing Brains

Relative Drug Risks and the Need for a Shift in Cultural Perceptions of Alcohol

Sleep Deprivation and the Triple Therapy for Depression

The SAINT Study: Accelerated Neuromodulation Therapy for Depression

Dr. Nolan Williams: Psychedelics & Neurostimulation for Brain Rewiring

Huberman Lab

00:00Introduction to Depression and Psychedelic Treatments

Introduction to Depression and Psychedelic Treatments

03:32The Debilitating Nature of Depression and its Impact on Physical Health

The Debilitating Nature of Depression and its Impact on Physical Health

10:14The Disparity in Acute Care for Psychiatric vs. Physical Illnesses and Brain-Heart Connections

The Disparity in Acute Care for Psychiatric vs. Physical Illnesses and Brain-Heart Connections

14:14Lateralization of Function in the Dorsolateral Prefrontal Cortex

Lateralization of Function in the Dorsolateral Prefrontal Cortex

18:41Heart Rate Variability, Depression, and Behavioral Interventions

Heart Rate Variability, Depression, and Behavioral Interventions

24:58The Role of the Parasympathetic Nervous System and the Dorsolateral Prefrontal Cortex in Mood Regulation

The Role of the Parasympathetic Nervous System and the Dorsolateral Prefrontal Cortex in Mood Regulation

32:21The Stroop Task, Belief Systems, and the Dorsolateral Prefrontal Cortex

The Stroop Task, Belief Systems, and the Dorsolateral Prefrontal Cortex

39:34The Role of TMS in Enhancing Cognitive Function and the Timing of Brain Regions in Depression

The Role of TMS in Enhancing Cognitive Function and the Timing of Brain Regions in Depression

45:53The Cingulate Cortex, Dissociation, and Contrasting Drug Effects on Depression

The Cingulate Cortex, Dissociation, and Contrasting Drug Effects on Depression

53:04Ketamine's Mechanism of Action and the Importance of Underlying Biology in Psychedelic Treatments

Ketamine's Mechanism of Action and the Importance of Underlying Biology in Psychedelic Treatments

1:01:04SSRIs, Serotonin, and the Circuitry of Depression

SSRIs, Serotonin, and the Circuitry of Depression

1:09:13The Power of Control and the Role of Psychedelics in Recovering from Psychiatric Illnesses

The Power of Control and the Role of Psychedelics in Recovering from Psychiatric Illnesses

1:17:27MDMA and its Effects on Trauma and the Brain

MDMA and its Effects on Trauma and the Brain

1:25:30Serotonin, Dopamine, and the Effects of Psilocybin on the Brain

Serotonin, Dopamine, and the Effects of Psilocybin on the Brain

1:34:04Exposure Response Prevention Therapy and the Spectrum of Mental Health

Exposure Response Prevention Therapy and the Spectrum of Mental Health

1:42:53Ibogaine: A Unique Psychedelic for Addiction and Trauma

Ibogaine: A Unique Psychedelic for Addiction and Trauma

1:52:345-MeO-DMT, Ayahuasca, and the Potential for Psychedelics in Criminal Rehabilitation

5-MeO-DMT, Ayahuasca, and the Potential for Psychedelics in Criminal Rehabilitation

2:04:04Cannabis: CBD vs. THC and the Risks for Developing Brains

Cannabis: CBD vs. THC and the Risks for Developing Brains

2:12:14Relative Drug Risks and the Need for a Shift in Cultural Perceptions of Alcohol

Relative Drug Risks and the Need for a Shift in Cultural Perceptions of Alcohol

2:23:21Sleep Deprivation and the Triple Therapy for Depression

Sleep Deprivation and the Triple Therapy for Depression

2:31:15The SAINT Study: Accelerated Neuromodulation Therapy for Depression

The SAINT Study: Accelerated Neuromodulation Therapy for Depression